BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17969309)

  • 1. [The importance of ACE2 in regulating the cardiovascular system].
    Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
    Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
    Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2: a new target for cardiovascular disease therapeutics.
    Raizada MK; Ferreira AJ
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiological significance of the alternative pathways of angiotensin II production.
    Kramkowski K; Mogielnicki A; Buczko W
    J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects.
    Keidar S; Strizevsky A; Raz A; Gamliel-Lazarovich A
    Nephrol Dial Transplant; 2007 Feb; 22(2):597-601. PubMed ID: 17095582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2 and the kidney.
    Soler MJ; Wysocki J; Batlle D
    Exp Physiol; 2008 May; 93(5):549-56. PubMed ID: 18223023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
    Mendoza-Torres E; OyarzĂșn A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2, a new regulator of the renin-angiotensin system.
    Burrell LM; Johnston CI; Tikellis C; Cooper ME
    Trends Endocrinol Metab; 2004; 15(4):166-9. PubMed ID: 15109615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial infarction increases ACE2 expression in rat and humans.
    Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
    Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New fACEs to the renin-angiotensin system.
    Fleming I; Kohlstedt K; Busse R
    Physiology (Bethesda); 2005 Apr; 20():91-5. PubMed ID: 15772297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
    Hamming I; van Goor H; Turner AJ; Rushworth CA; Michaud AA; Corvol P; Navis G
    Exp Physiol; 2008 May; 93(5):631-8. PubMed ID: 18192334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme II in the heart and the kidney.
    Danilczyk U; Penninger JM
    Circ Res; 2006 Mar; 98(4):463-71. PubMed ID: 16514079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis: a balance of ACEs?
    Warner FJ; Lubel JS; McCaughan GW; Angus PW
    Clin Sci (Lond); 2007 Aug; 113(3):109-18. PubMed ID: 17600527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?
    Patel SK; Velkoska E; Burrell LM
    Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):551-9. PubMed ID: 23432153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ACE2 in cardiovascular physiology.
    Oudit GY; Crackower MA; Backx PH; Penninger JM
    Trends Cardiovasc Med; 2003 Apr; 13(3):93-101. PubMed ID: 12691672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological roles of angiotensin-converting enzyme 2.
    Danilczyk U; Eriksson U; Oudit GY; Penninger JM
    Cell Mol Life Sci; 2004 Nov; 61(21):2714-9. PubMed ID: 15549172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between renal injury and the antagonistic roles of angiotensin-converting enzyme (ACE) and ACE2.
    Ma C; Xin H; Jiang XY; Wang YX; Zhang YS
    Genet Mol Res; 2014 Apr; 13(2):2333-42. PubMed ID: 24781988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
    Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
    Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
    Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
    Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.